Chlorcyclizine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H21ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M26C4IP44P, chemically known as piperazine, 1- (p-chloro-.alpha.-phenylbenzyl)-4-methyl-, monohydrochloride but generally known as chlorcyclizine, which bears US NIH Compound Identifier 2710. European Medicines Agency schedules Chlorcyclizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06178MIG. The term CHLORCYCLIZINE is an International Non-Proprietary Name. World Health Organization schedules chlorcyclizine in its Anatomical Therapeutic Chemical (ATC) Classification. CHLORCYCLIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule chlorcyclizine under HS 29335995 and SITC 51576. As of Q4 2014, CHLORCYCLIZINE remains the US FDA Preferred Term for this commodity. Chlorcyclizine bears US NLM identifiers UMLS ID C0008183 and NCI Concept Code C81138. SMILES: CLC1CCC(C(N2CCN(CC2)C)C2CCCCC2)CC1.